DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Sledge GW, Neuberg D, Bernardo P. et al.
Phase III trial of doxorubicin, paclitaxel, and the combination of doxorubicin and paclitaxel as front-line chemotherapy for metastatic breast cancer: an intergroup trial (E1193).
J Clin Oncol 2003;
21: 588-592
doi:10.1200/JCO.2003.08.013
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.